The global syphilis immunoassay diagnostics market, valued at $548.5 million in 2023, is projected to grow at a CAGR of 5.5%, reaching $978.5 million by 2034. This growth is driven by increasing syphilis prevalence, advancements in diagnostic technologies like CLIA and ELISA, and the expansion of point-of-care testing, particularly in resource-limited settings. https://www.transparencymarketresearch.com/syphilis-diagnostics-market.html